The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …

Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) in children are becoming increasingly apparent as the coronavirus disease (COVID …

The long-term sequelae after SARS-CoV-2 infections in children is unknown. Guidance is
needed on helpful models of care for an emerging subset of pediatric patients with …

Neurologic manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection in pediatric patients have been reported in the acute and postinfectious stages of …

Most children with SARS-CoV-2 infection have relatively mild clinical symptoms without
fever or pneumonia, although severe cases with multiple-organ failure have been reported …

Immunization by means of vaccination is a global health success story, saving millions of
lives every year. In this regard, the epidemiology of measles, rabies, polio, rubella, varicella …

Background In the pediatric population, the knowledge of the acute presentation of SARS-
CoV-2 infection is mainly limited to small series and case reports, particularly when dealing …

Background Serum neurofilament light chain (sNfL) is an established biomarker of neuro-
axonal damage in multiple neurological disorders. Raised sNfL levels have been reported in …

Febrile seizures (FS) are well-known manifestations of viral illnesses. The purpose of this
study is to assess the prevalence and factors associated with FS among pediatric patients …

There is insufficient evidence on SARS-CoV-2 induced neurological effects. Studies on CNS
involvement during COVID-19 in children are limited. This study aims to identify and manage …